| ¿µ¹® | specific gravity | ÇÑ±Û | ºñÁß |
|---|---|---|---|
| ¼³¸í | ´ÜÀ§ ºÎÇÇ´ç Áú·®. ¼Òº¯ÀÇ ºñÁßÀº ¼Òº¯ÀÇ ³óµµ¸¦ ¹Ý¿µÇÑ´Ù. ¿¹¸¦ µé¾î ¼Òº¯ÀÇ ºñÁßÀÌ Å©¸é, ÄáÆÏÀÇ ¹°Èí¼ö°¡ ¿øÈ°È÷ ÀÌ·ç¾îÁö°í ÀÖÀ½À» ³ªÅ¸³½´Ù. |
||
| ¿µ¹® | neutrophil | ÇÑ±Û | Áß¼º±¸ |
|---|---|---|---|
| ¼³¸í | ¿°»ö»ó »êµµ°¡ Áß¼ºÀÎ »óÅ¿¡¼ ¼¼Æ÷Áú³»¿¡ Á¸ÀçÇÏ´Â ¿©·¯ °ú¸³µéÀÌ ³ªÅ¸³ª±â ¶§¹®¿¡ Áß¼º±¸¶ó°í ºÒ¸®¸ç, ¶ÇÇÑ ¼¼Æ÷³»ÀÇ ÇÙÀÇ ÇüŰ¡ ´Ù¾çÇϹǷΠ´ÙÇü¹éÇ÷±¸¶ó°íµµ ÇÑ´Ù. ±â´ÉÀº ÁÖ·Î ½Åü³»¿¡ ħÀÔÇÏ´Â º´±ÕÀ» Àâ¾Æ¸ÔÀ½À¸·Î½á Ç×±ÕÀÛ¿ëÀ» ¼öÇàÇÑ´Ù. |
||
| ¿µ¹® | carcinoembryonic antigen | ÇÑ±Û | ¾Ï¹è¾ÆÇ׿ø |
|---|---|---|---|
| ¼³¸í | ¿ø·¡ žÆÀÇ ÀåÁ¶Á÷¿¡¼ Á¤»óÀûÀ¸·Î Á¸ÀçÇÏ´Â ¹°Áú·Î žƱâ ÀÌÈÄ¿¡´Â Á¸ÀçÇÏÁö ¾Ê´Â ¹°ÁúÀÌ´Ù. ±×·¯³ª À§, °£, ÇãÆÄ µîÀÇ ¾ÏÀÌ ÀÖ´Â °æ¿ì¿¡ ¼ºÀο¡¼µµ Á¸ÀçÇÑ´Ù. À̸¦ ÀÌ¿ëÇØ¼ ¾ÏÀÇ Ä¡·áÈ¿°ú ÆÇÁ¤À̳ª Àç¹ß¿©ºÎÀÇ Á¶»ç¿¡ ÀÌ¿ëÇÑ´Ù. |
||
| ¿µ¹® | antigen | ÇÑ±Û | Ç׿ø |
|---|---|---|---|
| ¼³¸í | ƯÀÌÇÑ ¸é¿ª¹ÝÀÀÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Â ¾î¶°ÇÑ ¹°Áú. ¿©±â¿¡¼ ¸»Çϴ ƯÀÌÇÑ ¸é¿ª¹ÝÀÀÀ̶õ ºñƯÀÌÀûÀÎ ¸é¿ª¹ÝÀÀ°ú´Â ¹Ý´ëµÇ´Â Àǹ̷Π±× ¹°Áú¿¡ ´ëÇØ¼ ƯÀÌÇÏ°Ô ¹ÝÀÀÇÒ ¼ö ÀÖ´Â Ç×ü³ª ±× ¹°Áú¿¡ ´ëÇØ¼ ƯÀÌÇÏ°Ô ¹ÝÀÀÇÒ ¼ö ÀÖ´Â ¼¼Æ÷¸¦ ¸¸µå´Â °ÍÀ» ¸»ÇÑ´Ù. |
||
| TSA | technical surgical assistance; toluene sulfonic acid; total shoulder arthroplasty; total solute abso... |
|---|---|
| TSTA | toxoplasmin skin test antigen; tumor-specific tissue antigen; tumor-specific transplantation antigen... |
| NAP | nasion, point A, pogonion [convexity or concavity of the facial profile]; nerve action potential; ne... |
| HLA | histocompatibility leukocyte antigen; histocompatibility locus antigen; homologous leukocyte antibod... |
| HBsAg/adr | hepatitis B surface antigen manifesting group-specific determinant a and subtype-specific determinan... |
| GSA | Group-specific antigen |
|---|---|
| NCA | Non-specific cross-reacting antigen |
| PSA | Prostate Specific Antigen |
| PSMA | Prostate Specific Membrane Antigen |
| PSM | Prostate specific membrane antigen |
| site-specific DNA-methyltransferase (adenine-specific) | <enzyme> An enzyme responsible for producing a species-characteristic methylation pattern on adenine residues in a specific short base sequence in the host cell DNA. The enzyme catalyses the methylation of DNA adenine in the presence of s-adenosyl-l-methionine to form DNA containing 6-methylaminopurine and s-adenosyl-l-homocysteine. Registry number: EC 2.1.1.72 (12 Dec 1998) |
|---|---|
| site-specific DNA methyltransferase (cytosine-specific) | <enzyme> An enzyme responsible for producing a species-characteristic methylation pattern on cytosine residues in a specific short base sequence in the host cell's DNA. The enzyme catalyses the methylation of DNA cytosine in the presence of s-adenosyl-l-methionine to form s-adenosyl-l-homocysteine and DNA containing 5-methylcytosine. Registry number: EC 2.1.1.73 (12 Dec 1998) |
| prostate-specific antigen | <tumour marker> A simple blood test used to detect prostate cancer in men. The test measures a specific antigen normally secreted by the prostate. If cancer is developing, the prostate secretes greater amounts of prostate-specific antigen. This test is recommended for men with an enlarged prostate and an increased risk of prostate cancer. It is an enzyme that is produced by epithelial cells of both benign and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer. It is a single chain 31 kilodalton glycoprotein with 240 amino acid residues and 4 carbohydrate side chains that is a kallikrein protease. It is found in normal seminal fluid and produced by the prostatic epithelial cells. Elevated levels in blood serum are associated with prostatic enlargement and prostatic adenocarcinoma, and this allows early detection of cancer in many cases. In about 70% of cases, the rise is due to a cancerous condition. No large scale clinical studies have been completed to assess the impact of testing on survival from prostate cancer, and the medical and economic value of testing remain uncertain. Acronym: PSA Registry number: EC 3.4.21.77 (22 Sep 2002) |
| species-specific antigen | Antigenic components in the tissues and fluids of members of a species of animal, by means of which various species may be immunologically distinguished; e.g., serum albumin of horses is immunologically different from that of man, dogs, sheep, and so on. (05 Mar 2000) |
| organ-specific antigen | A heterogenetic antigen with organ specificity; e.g., in addition to species-specific antigen, kidney of one species contains antigen that is identical to that in kidney of other species. Synonym: tissue-specific antigen. (05 Mar 2000) |
| tissue-specific antigen | A heterogenetic antigen with organ specificity; e.g., in addition to species-specific antigen, kidney of one species contains antigen that is identical to that in kidney of other species. Synonym: tissue-specific antigen. (05 Mar 2000) |
| tumour specific antigen | <immunology, oncology> Antigen on tumour cells detected by cell-mediated immunity. For virus transformed cells TSTA (unlike T antigen) is found to differ for different individual tumours induced by the same virus. May consist of fragments of T antigens exposed at the cell surface. (18 Nov 1997) |
| anionic neutrophil activating peptide | <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes. It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4. Acronym: IL-8 (12 Dec 1998) |
| band neutrophil | <pathology> Immature neutrophils released from the bone marrow reserve in response to acute demand. (18 Nov 1997) |
| mature neutrophil | A fully matured neutrophil that has at least 2 (and as many as 5) distinct lobes in the nucleus and manifests active ameboid motion. Synonym: mature neutrophil. (05 Mar 2000) |
| monocyte derived neutrophil chemotactic factor | <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes. It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4. Acronym: IL-8 (12 Dec 1998) |
| segmented neutrophil | A fully matured neutrophil that has at least 2 (and as many as 5) distinct lobes in the nucleus and manifests active ameboid motion. Synonym: mature neutrophil. (05 Mar 2000) |
| hypersegmented neutrophil | An aged and degenerated neutrophil in which there may be 6 to 10 lobes in the nucleus. Immature neutrophil, a young neutrophil; the term is usually used with reference to stab neutrophil's (or other "juvenile" neutrophil's), neutrophilic granulocytes in which the nucleus is indented but not distinctly segmented. Juvenile neutrophil, any cell of the granulocytic series in which the neutrophilic granules are recognizable and the nucleus is indented (the first phase of segmentation). (05 Mar 2000) |
| stab neutrophil | <pathology> Immature neutrophils released from the bone marrow reserve in response to acute demand. (18 Nov 1997) |
| neutrophil | <haematology> A granulocyte, a white blood cell. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|